Marketing clearance from U.S. FDA for Medical HAL.

The FDA clearance on October 2, 2020 recognizes Medical HAL’s indication for use and its medical effect
such as “temporarily help improve ambulation upon completion of the HAL gait training intervention” (not
to enable individuals to perform ambulatory functions while it is worn) for wider range of diseases.

For more info, please visit (EN):

Nasi partnerzy

fundusze unijne, contance care